Phase 1 First in Human Study of ZN-d5 as a Single Agent
Clinical trial NCT04500587 · COMPLETED
Trial details
- NCT number
- NCT04500587
- Sponsor
- K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2023-12-12
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.